Trinity Biotech annual return on equity
2016
2017
2018
2019
2020
Trinity Biotech Return on Equity (ROE) Growth & History (TRIB)
Trinity Biotech's return on equity was −482.20% for fiscal 2020.
View full Trinity Biotech company overviewTrinity Biotech annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2020 | 2020-12-31 | −482.20% | −363.30 pp |
| 2019 | 2019-12-31 | −118.90% | −77.42 pp |
| 2018 | 2018-12-31 | −41.48% | +2.98 pp |
| 2017 | 2017-12-31 | −44.46% | −20.54 pp |
| 2016 | 2016-12-31 | −23.92% | — |
Trinity Biotech quarterly return on equity
Q2.18
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2018 | 2018-06-30 | 0.90% | — |
Trinity Biotech return on equity trends
Between the periods ended 2016-12-31 and 2020-12-31, Trinity Biotech's return on equity decreased from −23.92% to −482.20%, a change of −458.28 percentage points. The latest reported quarter, Q2 2018, shows 0.90%.
About the metric
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
Calculation and source
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Trinity Biotech source filings ↗